comparemela.com

Latest Breaking News On - Sumant kulkarni - Page 4 : comparemela.com

Intra-Cellular Therapies, Inc (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript

Operator: Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.

It s Really a Brain Chemistry Issue : Elon Musk Embraces Ketamine in the Battle Against Depression — Here Are 2 Psychedelic Stocks That Analysts Like

Thinking outside the box has been a hallmark of Elon Musk’s behavior, and now you might be curious about how he actually reaches those ‘out of the box’ thought patterns. Musk has recently been touting the credentials of ketamine, an anesthetic known for its dissociative qualities. The Tesla CEO has said that he occasionally indulges in microdosing of the drug, believing it to be a better choice than traditional antidepressants for treating depression. Musk has also mentioned experiencing depress

Insiders Pour Millions Into These 2 Strong Buy Stocks — Here s Why You Might Want to Steer Toward Them Too

For investors seeking a clear path in the markets, a signal that cuts through all the noise and identifies stocks likely to gain, corporate insiders cannot be ignored. We’re referring to corporate officers who hold high posts of responsibility within their firms: CEOs, COOs, CFOs, Exec VPs, and members of the Board. These positions provide them with two undeniable attributes: a macro-view of the company and its prospects, and a need to answer to shareholders and directors for company performance

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.